KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

ACRX Predictions History

4 years ago
NameNotImportant predicted that ACRX for 2019-05-02 is going $3.77 (1.62%)

5 years ago
NameNotImportant predicted that ACRX for 2019-04-29 is going $3.85 (-2.04%)

5 years ago
NameNotImportant predicted that ACRX for 2019-04-23 is going $3.42 (-2.56%)

5 years ago
ss predicted that ACRX for 2019-04-22 is going $3.45 (2.07%)

Rank:

5 years ago
Profit.Prophet.108044 predicted that ACRX for 2019-04-22 is going $3.41 (0.89%)

5 years ago
JS predicted that ACRX for 2019-04-22 is going $3.40 (0.59%)

5 years ago
PumpTheseNumbers predicted that ACRX for 2019-04-22 is going $3.42 (1.18%)

5 years ago
NameNotImportant predicted that ACRX for 2019-04-22 is going $3.37 (-0.30%)

5 years ago
JS predicted that ACRX for 2019-04-15 is going $3.47 (2.36%)

5 years ago
PumpTheseNumbers predicted that ACRX for 2019-04-15 is going $3.48 (2.65%)

Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT